Chemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsAdjuvants, ImmunologicCombined Modality TherapyBreast NeoplasmsCyclophosphamideNeoplasm StagingDisease-Free SurvivalTreatment OutcomeRadiotherapy, AdjuvantCisplatinAntineoplastic AgentsDoxorubicinSurvival AnalysisPrognosisFluorouracilNeoplasm Recurrence, LocalFreund's AdjuvantSurvival RateMethotrexateNeoadjuvant TherapyAdjuvants, PharmaceuticDrug Administration ScheduleLymphatic MetastasisLung NeoplasmsAntimetabolites, AntineoplasticTegafurFollow-Up StudiesPaclitaxelAnthracyclinesCarboplatinAdenocarcinomaTaxoidsEpirubicinLevamisoleEtoposideVinblastineColonic NeoplasmsTamoxifenMastectomyKaplan-Meier EstimateColorectal NeoplasmsCarcinoma, Non-Small-Cell LungOrganoplatinum CompoundsTime FactorsRandomized Controlled Trials as TopicNeoplasm MetastasisClinical Trials as TopicDeoxycytidineStomach NeoplasmsAntineoplastic Agents, HormonalTumor Markers, BiologicalAntineoplastic Agents, AlkylatingProspective StudiesLomustineIfosfamideReceptors, EstrogenBleomycinSarcomaDrug Resistance, NeoplasmTesticular NeoplasmsMultivariate AnalysisProportional Hazards ModelsOsteosarcomaRadiotherapyReceptor, erbB-2Retrospective StudiesOvarian NeoplasmsCystectomyAntibiotics, AntineoplasticGastrectomyRectal NeoplasmsNeoplasmsOxonic AcidInduction ChemotherapyBone NeoplasmsLeucovorinMitomycinNeutropeniaThiotepaPremenopauseUracilAntineoplastic Agents, PhytogenicPneumonectomyRecurrenceCarcinomaClinical Trials, Phase III as TopicLymph NodesLymph Node ExcisionSalvage TherapyBrain NeoplasmsNeoplasms, Germ Cell and EmbryonalRadiotherapy DosageAntineoplastic ProtocolsMedical OncologyVomitingBridged CompoundsDacarbazineSemustineGranulocyte Colony-Stimulating Factor